RLX is an inhibitor of PI3K/akt/FoxO3a signalling in experimental colon cancer. References: Garella R, Squecco R, Baccari MC. Site-related Effects of Relaxin in the Gastrointestinal Tract Through Nitric Oxide Signalling: An Updated Report. Curr Protein Pept Sci. 2017;18(12):1254-1262. doi: 10.2174/1389203718666170612104719. Review. PubMed PMID: 28606038.

纯度：≥98%

CAS：4425-23-4